Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

A doctor has issued a warning about a less documented side effect of Ozempic that can apparently have a long-term health ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

TWO blockbuster weight loss just have been tested against each other for the first time in a head-to-head trial. There was a clear winner, which saw slimmers shed 20 per cent of their body weight.

Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating ...

Both Mounjaro and Wegovy are GLP-1 receptor agonists. So, GLP-1 is basically usually released after eating, sending a signal to your brain that you’re full up and delaying the e ...

Wegovy can cause some side effects. The most common side effects of semaglutide are nausea, vomiting, and diarrhoea. Other ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

But new research suggests these drugs could be doing more than helping people shed pounds. Scientists at the University of ...

The global market for Ozempic, Wegovy and similar drugs is projected to explode during the next five years. Fashion - which ...